Hi, I’m Niklas Rindtorff. I am building tools for affinity reagent design at convexity labs. The future I am working towards is one in which the effort to design a molecule with a useful property, such as specific, non-covalent binding, is too cheap to meter.

Previously, I developed a microscopy-based, small molecule screening platform using patient derived cancer organoids. This approach can be used to discover new therapeutics, or to prioritise treatment options for cancer patients.

I studied medicine at Heidelberg university and biomedical informatics at Harvard. I did my research at the German Cancer Research Center and at the Broad Institute.

I care a lot about technological progress, ways to improve scientific productivity, and freedom.